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Abstract
Background: Behavior change methods involving new ambulatory technologies may improve lifestyle and cardiovascular
disease outcomes.
Objective: This study aimed to provide proof-of-concept analyses of an intervention aiming to increase (1) behavioral flexibility,
(2) lifestyle change, and (3) quality of life. The feasibility and patient acceptance of the intervention were also evaluated.
Methods: Patients with cardiovascular disease (N=149; mean age 63.57, SD 8.30 years; 50/149, 33.5% women) were recruited
in the Do Cardiac Health Advanced New Generation Ecosystem (Do CHANGE) trial and randomized to the Do CHANGE
intervention or care as usual (CAU). The intervention involved a 3-month behavioral program in combination with ecological
momentary assessment and intervention technologies.
Results: The intervention was perceived to be feasible and useful. A significant increase in lifestyle scores over time was found
for both groups (F2,146.6=9.99; P<.001), which was similar for CAU and the intervention group (F1,149.9=0.09; P=.77). Quality of
life improved more in the intervention group (mean 1.11, SD 0.11) than CAU (mean −1.47, SD 0.11) immediately following the
intervention (3 months), but this benefit was not sustained at the 6-month follow-up (interaction: P=.02). No significant treatment
effects were observed for behavioral flexibility (F1,149.0=0.48; P=.07).
Conclusions: The Do CHANGE 1 intervention was perceived as useful and easy to use. However, no long-term treatment
effects were found on the outcome measures. More research is warranted to examine which components of behavioral interventions
are effective in producing long-term behavior change.
Trial Registration: ClinicalTrials.gov NCT02946281; https://www.clinicaltrials.gov/ct2/show/NCT02946281
(J Med Internet Res 2020;22(5):e14570) doi: 10.2196/14570
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The elimination of modifiable behavioral risk factors for
cardiovascular disease (eg, smoking and physical inactivity) in
the general population could prevent 80% of adverse clinical
outcomes [1]. In patients diagnosed with cardiovascular disease,
a modest reduction in risk behaviors can decrease the mortality
rates by approximately 50% [2]. However, recommended targets
(eg, lifestyle and medication adherence) for secondary
prevention are rarely reached [3]. To achieve sustained health
behavior change, active interventions that go beyond patient
education are needed [4].
Sustainable behavior changes can be enhanced by implementing
a personalized patient-tailored approach [5,6]. New ambulatory
technologies can now be used to provide personalized support
in a low threshold, nonobtrusive, and ecologically valid manner.
These devices can be used to provide feedback about ambulatory
health behaviors (eg, physical activity levels), but they are not
sufficient to produce long-term behavior change [7,8]. In the
setting of cardiac rehabilitation, telemonitoring guidance for
patients’ physical activity levels was found to be feasible in the
FIT@Home study, and this intervention resulted in higher
patient satisfaction and trends toward lower health care costs,
but not in better improvements in fitness or physical activity
levels relative to standard center-based rehabilitation [8]. The
impact of this intervention could potentially have been further
improved if a more patient-tailored approach were added.
Another study found initial support that an app using persuasive
design techniques can improve biological and psychological
factors in patients after cardiac rehabilitation [9]. It is therefore
plausible that ambulatory assessments are likely to have better
therapeutic effects when combined with prompts that promote
health-related behaviors (ie, ecological momentary
interventions). These new methodologies also require a deeper
knowledge about patients’ needs and preferences [10].
This trial (Do Cardiac Health Advanced New Generation
Ecosystem, Do CHANGE) was specifically designed to examine
this multidisciplinary approach to behavior change [11]. What
is unique to this trial is that patients received the behavior
change program, Do Something Different (DSD), which has
been previously developed to change unhealthy habits through
the increase of behavioral flexibility [11]. Behavioral flexibility
is associated with a broad range of the behavioral repertoire,
making people more open to experience and the adoption of
new behaviors [12]. DSD has been evaluated in other patient
samples and has shown promising results by producing health
behavior change [13]. For this study, the program was adapted
to meet the needs of patients with cardiovascular disease
(coronary artery disease, CAD; heart failure, HF; and
hypertension, HT). Hence, the aim of this study was to provide
proof of concept for the behavioral intervention aiming to
address (1) behavioral flexibility, (2) lifestyle change, and (3)
quality of life. The feasibility and patient acceptance of the
intervention were also evaluated.
Methods
Design
The Do CHANGE trial is an international (the Netherlands and
Spain), multicenter, randomized controlled trial, designed to
enhance lifestyle changes in patients with cardiac disease
(NCT02946281). The trial findings described in this paper are
the first (proof of concept and feasibility) phase of the Do
CHANGE project (phase 1) and will serve as input for further
development of a second phase of this randomized controlled
trial (Do CHANGE, phase 2; NCT03178305). A detailed
description of both phases of the Do CHANGE trial has been
published previously [11]. As this trial was developed to provide
information about proof of concept and feasibility, an a priori
sample size calculation was not performed. For this phase, we
aimed to include 150 patients across 2 countries, which is
considered sufficient to give information about proof of concept
and feasibility of the intervention.
Study Sample
Patients diagnosed with CAD (having experienced a myocardial
infarction, percutaneous coronary intervention, angina pectoris,
or coronary artery bypass graft surgery), symptomatic HF (New
York Heart Association class I-IV), and HT were included in
the study. HT was defined as systolic blood pressure ≥140 mm
Hg and/or diastolic blood pressure ≥90 mm Hg on two different
measurements spaced 1 to 2 min apart and after 3 to 5 min in a
sitting position. The values of the second measure were used.
HF patients were included if they had a diagnosis of systolic or
diastolic HF and the presence of HF symptoms.
Patients were recruited at Badalona Serveis Assistencials
(Badalona, Spain) and Elisabeth-TweeSteden Hospital (Tilburg,
the Netherlands). The study was approved by the medical ethics
committees of the participating hospitals and was conducted in
accordance with the Helsinki Declaration.
The inclusion criteria were as follows: (1) a primary diagnosis
of CAD, HF, or HT; (2) aged 18 to 75 years; (3) having ≥2 of
the following risk factors: positive family history, increased
cholesterol, smoking, diabetes, sedentary lifestyle, and/or
psychosocial risk factors; (4) sufficient knowledge of the
country’s native language; (5) access to the internet at home;
and (6) having a smartphone compatible with the apps used in
the study.
The exclusion criteria were as follows: (1) life expectancy <1
year, (2) life-threatening comorbidities (eg, malignancy), (3)
history of psychiatric illness other than anxiety and/or
depression, (4) significant cognitive impairments (eg, dementia),
and (5) on the waiting list for heart transplantation.
Procedure
Patients meeting the inclusion criteria were approached for
participation by a cardiologist or cardiac nurse. If interested,
patients received information about the study in writing and
orally. After 10 days, patients were contacted to inquire about
their participation. If the patient indicated that they wanted to
participate, a face-to-face appointment was scheduled at the
hospital. Patients were asked to sign an informed consent
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document and were provided with the first set of questionnaires
(baseline). After filling in the questionnaires, patients were
randomized. Patients in the intervention group received
information about the intervention and the use of associated
devices (see the Intervention section). The following day,
patients in the intervention group were contacted by telephone
to check that the devices were installed correctly and that the
system was functional.
Patients received the intervention for 3 months. Follow-up
questionnaires were sent at 3 and 6 months. Patients returned
the devices after completion of the intervention (ie, after 3
months).
Randomization and Blinding
Patients were randomized (1:1) after completing the baseline
questionnaires. Randomization sequences were computer
generated and individually sealed before recruitment started.
After completing the questionnaires, one sealed envelope was
drawn by the research assistant containing the group allocation.
Owing to the nature of the behavioral monitoring aspects of the
study, blinding health care providers or participants to the
treatment condition was not possible, whereas the initial analyses
of the study outcomes were analyzed without knowledge of the
treatment allocation.
Intervention
Do Cardiac Health Advanced New Generated Ecosystem
Intervention Versus Care as Usual
Behavior Change Technique
Patients randomized to the intervention group received a
3-month behavior change program, DSD, which was provided
via text messages on patients’mobile phones. The DSD program
that was used aims to change unhealthy habits through the
increase of behavioral flexibility [12]. This is achieved by
disrupting patients’ daily behavioral routine for a short period
(few seconds) with behavioral prompts, which are referred to
as Do’s (eg, “EXPLORE MORE DAY. Today instead of going
the same old way, take a different route. Look around, spot 10
things you wouldn't see on your usual journey”) and are
provided through patients’ mobile phones. These messages
challenge patients to do something different and get out of their
comfort zone. They have been developed by a multidisciplinary
team, including cardiologists and psychologists, to make sure
that the Do’s apply to the patient population and are thus related
to their daily behaviors/needs. Patients received a total of 32
Do’s during the 3-month intervention period (2-3 Do’s every
week). DSD has been evaluated in other patient samples and
has shown promising results with respect to behavior change
[13]. For this trial, the program was adapted to the cardiac
population with slight differences in the program depending on
patients’primary diagnosis (eg, CAD, HF, HT), as the preferred
health behaviors may vary depending on the diagnosis. For
example, because of disease-specific symptoms, advice
regarding fluid intake was taken into account within the program
only for patients with HF. More details regarding the DSD
program are provided in the previously published design paper
of this project [11].
Technological Tools
In addition to the DSD program, to obtain objective measures
on patients’ physical functioning, all patients received a blood
pressure monitor, the Moves app (ProtoGeo, Helsinki; to register
the GPS location), and the CarePortal (Docobo Ltd,
Leatherhead; eg, a home monitoring device measuring daily
symptoms and electrocardiogram). Owing to the disease-specific
reasons, patients diagnosed with HF also received a weight
scale, as daily weight monitoring is of importance in this
subgroup. Data obtained from these devices will not be included
in this analysis. This manuscript will focus on the primary
outcome measures related to lifestyle parameters and
patient-reported outcomes, which were derived from validated
questionnaires (see the study by Habibović et al [11] for a
description of primary and secondary outcomes).
Control Group
Patients randomized to the care as usual (CAU) group received
the treatment as usual and were only provided with the validated
questionnaires at baseline and at 3 and 6 months. These patients





Behavioral flexibility was measured using the DSD
questionnaire from scale items designed for this study [11]. This
scale contains 30 different descriptions of behavior coupled in
15 pairs of opposites (Multimedia Appendix 1). Patients were
asked at each measurement point to select the behaviors that
best describe them (eg, gentle or firm). On the basis of a formula,
the behavioral flexibility for each participant at each time point
was calculated as outlined below.
Every addition of behavior raises the score as well as when both
of a pair of opposite behaviors are added. For example, definite,
systematic, trusting, predictable, and unpredictable are selected.
All these selected behaviors raise the flexibility score. However,
because predictable and unpredictable are each other’s opposites,
these are added to the formula again and increase the flexibility
score even more. The model interprets this seemingly
contradictory behavior as evidence of flexibility: based on what
a given situation demands, the person can use different reactions
and thus be more flexible. The total score can range from 0 to
100. The internal consistency in this sample was considered
acceptable (Cronbach alpha=.67 to .76).
Lifestyle
The Health-Promoting Lifestyle Profile questionnaire was
administered to assess health-promoting lifestyle habits [14].
This survey evaluates whether the subjective perception of
patients regarding their lifestyle is changed and consists of 52
items (eg, “Eat 6-11 servings of bread, cereal, rice, and pasta
each day”) in total. Each item can be answered on a 4-point
Likert scale, ranging from 1 (never) to 4 (routinely). The total
score can therefore range from 52 to 208, with a higher score
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indicating a better lifestyle. Furthermore, the questionnaire
includes 6 different subscales that each cover a health promotion
lifestyle domain (ie, Physical Activity, Spiritual Growth, Health
Responsibility, Interpersonal Relationships, Nutrition, and Stress
Management). The internal consistency was considered as
excellent in this sample (Cronbach alpha=.88 to .90).
Quality of Life
To administer changes in the quality of life, participants
completed the World Health Organization Quality of
Life—BREF (WHOQOL-BREF) [15]. The WHOQOL-BREF
is considered a reliable, generic multidimensional quality of
life measure and consists of 26 items in total. Two items refer
to the facet’s overall quality of life and general health, whereas
the abiding 24 items reflect 4 different domains (ie, physical
health, psychological health, social relationships, and
environment). The internal consistency in this sample was
excellent (Cronbach alpha=.89 to .90).
Perceived Usefulness and Acceptance
The Unified Theory of Acceptance 2 (UTAUT2) scale [16] was
administered to assess the perceived usefulness and acceptance
of the tools that were used in the intervention. Mean scores on
8 subscales are provided, namely, (1) Performance Expectancy,
(2) Effort Expectancy, (3) Social Influence, (4) Facilitating
Conditions, (5) Hedonic Motivation, (6) Habit, and (7)
Behavioral Intention. The initial subscale, Price Value, of the
UTAUT2 was not included, as the cost per individual for the
intervention could not be estimated. The total score per subscale
can range from 4 to 20, with a higher score indicating higher
usefulness and acceptance [16]. The internal consistency in this
sample was excellent (Cronbach alpha=.89).
Client Satisfaction Questionnaire
To assess the satisfaction of the patients about the ecosystem,
the 8-item Client Satisfaction Questionnaire [17] was used. This
self-administered questionnaire is a general scale that consists
of 8 Likert scale items (eg, “To what extent has our program
met your needs?”) ranging from 0 to 4, with response descriptors
that vary. The overall score can range from 8 to 32, with a higher
score indicating a higher satisfaction. The internal consistency
was rated as excellent (Cronbach alpha=.92) [17].
Other Questionnaires Included in the Model
Type D Scale (Distress Scale-14)
Type D personality was assessed using the Type D scale
(Distress Scale-14) [18]. This 14-item questionnaire consists
of 2 subscales with seven 5-point Likert scale items each,
ranging from 0 (false) to 4 (true). Total scores on both subscales
range from 0 to 28. The 2 subscales represent the characteristics
of negative affectivity (NA; eg, the tendency to experience
negative emotions across time and situations) and social
inhibition (SI; eg, the tendency not to express feelings). When
scoring ≥10 on both subscales, patients were classified as Type
D. With a reported Cronbach alpha value of .86 and .88,
respectively, the internal consistency of SI and NA are
considered as satisfactory [18].
The 7-Item Generalized Anxiety Disorder Scale
To gauge self-administered symptoms of anxiety, the 7-item
Generalized Anxiety Disorder scale was administered [19]. The
questionnaire is comprised of 7 items (eg, “Feeling afraid as if
something terrible might happen”) that can be answered on a
4-point Likert scale, ranging from 0 (not at all) to 3 (almost
every day). To get an indication of anxiety symptom severity,
the total score (range from 0 to 21) can be used. A higher score
implies higher levels of anxiety. The internal consistency was
considered excellent (Cronbach alpha=.92) [19].
Nine-Item Patient Health Questionnaire
Depressive symptoms were administered at each time point by
using the 9-item Patient Health Questionnaire (PHQ-9) [20].
This self-report questionnaire consists of 9 items in total (eg,
feeling down, depressed, or hopeless), each evaluated on a
4-point Likert scale (ie, not at all, several days, and nearly every
day). The total score ranges from 0 to 27, with a higher score
as an indication of worse depression symptom severity. The
internal consistency was considered excellent (Cronbach
alpha=.90) [21].
Demographic and Clinical Data
Demographic characteristics (eg, age, sex, marital status,
working status, level of education, and smoking behavior) were
obtained by patients’ self-report. Clinical data (eg,
comorbidities; prescribed cardiac medication; prescribed
psychotropic medication; left ventricular ejection fraction;
history of coronary artery bypass grafting; history of
percutaneous coronary intervention; and resting heart rate and
systolic and diastolic blood pressure measured at the most recent
outpatient visit) were obtained from the medical record.
Statistical Analyses
Categorical variables were compared using chi-square tests,
and continuous variables were compared using a two-tailed t
test for independent samples. To evaluate the treatment
effectiveness, based on intention-to-treat, a univariate and
multivariate Linear Mixed Model analysis was performed.
Multivariable analyses were adjusted for age, sex, education,
site of inclusion (Badalona Serveis Assistencials [BSA] or
Elisabeth-TweeSteden Hospital [ETZ]), primary diagnosis,
Charlson comorbidity index scores, Type D personality, baseline
anxiety scores, and baseline depression scores. F values with
two-sided P values were reported for main and interaction
effects (group×time). For the estimated fixed effects, beta
coefficients with two-sided P values were reported. Data were
analyzed using the SPSS software package (version 24).
Results
Sample
The data collection took place between January 2017 and
September 2017. In total, 286 eligible patients were approached
for participation, of which 132/286 (46.1%) patients refused to
participate. An additional 5/286 (1.7%) participants did not
show up or declined participation. The reasons for refusal
included that it would be too time consuming, they did not want
to be confronted about their heart disease every day, and they
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were reluctant to use technology. A total of 149 (response rate:
149/286; 52.0%) patients were enrolled. Enrollment per study
site was as follows: BSA randomized a total of 74 (intervention:
n=37 and CAU: n=37) patients; ETZ randomized 75 patients
(intervention: n = 37 and CAU: n=38). Of the total sample, 4
participants within the CAU condition dropped out, as they did
not receive the intervention and were therefore not willing to
continue. Of the patients randomized to the intervention
condition, 82% (61/74) reported having completed the entire
3-month program. Overall, 97.3% (145/149) of the participants
completed the follow-up assessments. Figure 1 presents the
flowchart of patient recruitment.
Figure 1. Flow diagram of patient recruitment.
Baseline Characteristics
The mean age of the total sample was 63.6 (SD 8.3) years, and
66% (99/149) were men. There were significant differences
observed in mean completed education in years between the
intervention group (mean 14.3, SD 6.2) and the CAU group
(mean 11.8, SD 7.9; P=.03). This means that patients in the
intervention group completed more years of education than
those in the CAU group. Furthermore, a significant difference
between the 2 groups was found on the mean PHQ-9 baseline
scores, with a higher mean score on depressive symptoms in
the CAU group (mean 3.61, SD 3.6 vs mean 5.56, SD 4.17;
P=.003). No other differences were found between the
intervention and CAU groups. Table 1 presents an overview of
the baseline characteristics of this sample.
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Table 1. Baseline patient characteristics of the total sample.
P valueCare as usual
(N=75)
Do Cardiac Health Advanced New Generation
Ecosystem intervention (N=74)
TotalVariable
Site of allocation, n (%)
N/Aa37 (50)37 (50)74 (49.7)Badalona Serveis Assistencials
N/A38 (50.7)37 (49.3)75 (50.3)Elisabeth-TweeSteden Hospital
N/A75 (50.3)74 (49.7)149 (100)Total
Demographics
.6563.88 (8.30)63.26 (8,35)63.57 (8.30)Age (years), mean (SD)
.4247 (62.7)52 (70.3)99 (66.4)Gender (male), n (%)
.0311.79 (7.91)14.30 (6.24)13.03 (7.22)Education (years), mean (SD)
.4457 (76.0)61 (82.4)118 (79.2)Marital status (partner), n (%)
.9527 (36.0)28 (37.8)55 (36.9)Working status (working), n (%)
.2917 (22.7)10 (13.5)27 (18.1)Smoking (yes), n (%)
Clinical
.9615 (20.0)21 (28.4)36 (24.2)Diagnosis heart failure, n (%)
>.9935 (46.7)38 (51.4)73 (49.0)Diagnosis hypertension, n (%)
.0733 (33.3)15 (20.3)40 (26.8)Diagnosis coronary artery disease, n
(%)
.111.27 (1.00)1.01 (0.88)1.14 (0.95)Charlson comorbidity index, mean
(SD)
.06141.00 (18.13)135.00 (20.89)138.02 (19.71)Systolic blood pressure (baseline),
mean (SD)
.5479.77 (9.87)78.76 (10.33)79.27 (10.01)Diastolic blood pressure (baseline),
mean (SD)
.5968.88 (11.57)69.95 (14.43)69.41 (11.97)Heart rate (rest), mean (SD)
Psychological
.0035.56 (4.17)3.61 (3.60)4.59 (4.00)Patient Health Questionnaire-9, mean
(SD)
.064.69 (4.59)3.35 (4.07)4.03 (4.37)Generalized Anxiety Disorder-7, mean
(SD)




The univariate analysis on behavioral flexibility scores
(including group, time, and group×time) revealed no significant
main effects for group (F1,148.93=3.42; P=.07) or time
(F2,146.82=1.69; P=.18) and group×time interaction
(F2,146.82=1.09; P=.34). After adjusting for covariates (as
previously described), main effects for time (F1,146.81=1.74;
P=.18), group (F1,149.00=0.48; P=.07), and group×time
(F2,146.81=1.13; P=.33) remained nonsignificant (Figure 2). These
findings indicate that behavioral flexibility scores did not
significantly change over time, and that there were no
differences between the 2 groups. With regard to covariates
included in the model, the estimated fixed effects of HT
(β=−6.07; P=.01) and CAD (β=−5.57; P=.02) were significantly
associated with lower levels of behavioral flexibility scores
(across all time points). In addition, the site of recruitment was
associated with behavioral flexibility scores, with only patients
from Spain showing an increase in behavioral flexibility over
time (β=6.31; P<.01) when compared with those in the
Netherlands (see Table 2).
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Figure 2. Mean scores of intervention and care as usual group on primary outcome measures.
Figure 3. Standalone Equation 1.
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Table 2. Estimates of fixed effects from multivariable linear mixed models on the main outcome measures at baseline and at 3- and 6-month follow-up.
Quality of lifeLifestyleBehavioral flexibilityMultivariable linear mixed model
P valueSEEstimateP valueSEEstimateP valueSEEstimate
Model 1: unadjusted model
.791.890.51.543.522.18.032.074.70Intervention group













aCompared with the main diagnosis of heart failure.
Lifestyle
A univariate analysis showed no significant effect for group
(F1,434.91=0.91; P=.34) or group×time (F2,282.73=0.39; P=.68).
These findings present that, without the addition of possible
confounding variables, the intervention and CAU group did not
differ. In addition, no interaction effect between allocation to
group and time was found. However, a significant improvement
for both groups on overall reported lifestyle behavior was found
(F2,282.73=4.28; P=.02). When adjusting for covariates in the
multivariable analysis, this improvement remained significant
(F2,146.63=9.99; P<.001). As shown in Figure 2, both groups
reported improvements in lifestyle behavior over time. The
effects of interaction (F2,147.02=1.36; P=.26) and allocation to
group (F1,149.90=0.09; P=.77) remained nonsignificant in the
adjusted models. This indicated that no effect of the intervention
on healthy lifestyle behavior was found. The estimated fixed
effect of depression (β=−4.17; P=.03) was negatively associated
with lifestyle promoting behavior, indicating that patients who
score higher on the depression scale report lower healthy
lifestyle behaviors. Patients from Spain showed an increase in
lifestyle behavior (β=12.86; P<.01), in comparison with those
in the Netherlands (see Table 2).
Quality of Life
The results of the univariate analysis of the quality of life total
scores showed an interaction effect between time and group
(F2,146.40=4.22; P=.02). This finding indicates that the mean
scores on quality of life of the intervention and CAU groups
have different slopes over time: the intervention group showed
a small improvement in the quality of life after 3 months,
whereas the CAU group reported a small decline in the quality
of life (mean improvement 1.11, SD .11 vs mean −1.47, SD
.11). Both groups stabilized to baseline level after 6 months.
The interaction effect remained significant after adding the
covariates in the multilevel analysis (F2,146.52=4.29; P=.02;
Figure 2), suggesting a significant, positive effect of the
intervention on self-reported quality of life in the first 3 months.
The estimated fixed effects of higher levels of education (β=.25;
P=.02) and being recruited in Spain (β=4.62; P=.008) compared
with those in the Netherlands were significantly associated with
higher scores on quality of life. Lower scores were predicted
by higher CCI scores (β=−1.76; P=.05) anxiety (β=-0.90;
P=.03), and depression (β=−3.63; P<.01; see Table 2).
Examining subscales of the WHOQOL revealed no specific
subscale differences regarding response patterns to the
intervention.
Acceptability and Satisfaction
Overall, patients in the intervention group indicated being
satisfied with the intervention (mean 26.22, SD 4.82). The
intervention was perceived to be useful (mean 13.88, SD 3.96)
and easy to use (mean 17.07, SD 2.57). Patients did not feel
social pressure to use the devices from the intervention (mean
9.85, SD 3.63) and reported to be quite satisfied with the
possibilities to receive support (mean 15.44, SD 2.43) and had
a neutral opinion regarding the pleasure in using the devices
offered in the intervention (mean 10.63, SD 2.44). Furthermore,
the intervention was integrated relatively well in patients’ lives
(mean 11.71, SD 3.05). However, patients indicated that they
were neutral regarding the intention to use the ecosystem in the
future (mean 8.40, SD 3.34).
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This study aimed to provide proof of concept for the Do
CHANGE behavioral intervention targeting behavioral
flexibility, lifestyle change, and quality of life in cardiac
patients. No significant differences between the groups were
observed on behavioral flexibility and lifestyle. However, a
small increase in quality of life at 3 months was observed in the
intervention group, but at 6 months, no significant difference
between the groups was observed. With respect to the usefulness
and feasibility of the intervention, the findings of this study
revealed that the ecosystem is experienced as useful, easy to
use, and integrated well into the daily life of the patients. It
made the participants more aware of the fact that they must
undertake activities themselves to feel better. Patients also
reported feeling more safe because health care professionals
were watching along. Nonadherence is a common issue in
Web-based interventions for promoting health-related behavior,
and the average study results in only 50% of participants
adhering to the intended intervention [22]. However, 82.4% of
the patients participating in this Do CHANGE intervention
condition completed the intervention, which may further indicate
that the intervention was not perceived as demanding.
The findings of the study are not completely in line with
previous studies in other patient populations [13]. An
explanation for this discrepancy could be the fact that this was
the first study implementing the concept of behavioral flexibility
and thus the core Do’s of the DSD program in the cardiac
population. In addition, the Do’s might not have been tailored
enough to the patients’ needs that the timing of the Do’s might
not have been optimal. For example, one would want a patient
to receive a distractive Do at the time when the unwanted
behavior occurs. In this trial, patients from 2 different cultures
(Spain and the Netherlands) and diagnosed with different cardiac
disorders (ie, HT, HF, or CAD) were enrolled. This reflects the
heterogeneity of the sample, which may have affected the
results. Another important area for future research is the
exploration of the mediating factors that drive the interplay
between behavioral flexibility, lifestyle factors, and quality of
life in the setting to electronic health (eHealth) interventions.
Enrollment in the study may have increased the general
awareness of lifestyle change in both groups. This awareness
could unknowingly lead to the adaptation of a lifestyle,
independent of the allocation to a group. Previous research in
cardiac patients affirms that there is a relationship between
general knowledge about cardiac risk factors and self-reported
lifestyle changes in the short term [23]. Furthermore, although
lifestyle change is crucial in the treatment of cardiovascular
disease, there is a lack of emphasis on lifestyle change and
self-care of the patient in the current health care systems [24].
Addressing self-care and lifestyle change in clinical practice is
therefore warranted. The Do CHANGE trial provides
(longitudinal and momentary) knowledge that can be used in
the further development of personalized interventions that will
help patients reach recommended lifestyle goals.
Behavioral flexibility is an important construct on which
behavioral change can possibly be initiated. However, the results
of this study may indicate the need for a better measurement
tool, as the questionnaire that is used might not be sensitive
enough to reveal significant alteration in patients’ behavioral
flexibility over time.
The findings on quality of life, on the other hand, are not entirely
in line with previous studies in cardiac samples, which have
shown that there is a decline in quality of life and generally a
slight increase in anxiety and depression scores within the 3
months postcardiac event [25]. This could be explained by
patients having to adapt to new behaviors after visiting the
hospital and being reminded of the fact that they have a chronic
illness. In this study, the intervention group received the
behavioral program, which could have contributed to first an
increase in their quality of life, with a slight decrease after 3
months, sustaining their baseline quality of life. After the
behavioral intervention ends, the quality of life in the
intervention group also goes down as the additional support is
no longer provided.
The findings of this study must be interpreted in light of a few
limitations. At baseline, the intervention group and CAU group
showed some differences in mean years of completed education
and mean scores on depressive symptoms. The CAU group
scored significantly higher on both variables. Another limitation
of this study was that the sample was rather small, in relatively
good health, and clinically heterogeneous, which may have
limited the possibility to find substantial effects. Although the
intervention was positively evaluated by participants, half of
the approached patients did refuse participation. Therefore, it
can be concluded that eHealth interventions similar to those
described in this study are appealing for certain subgroups of
patients. Future research should focus on eHealth interventions
within the cardiac population based on a larger sample with
significant power that is assessed over a prolonged follow-up
duration (eg, beyond 6 months) to draw firm conclusions on
sustainable behavior change. The results of this study showed
that depression was associated with negative behavioral and
psychological outcomes, which is in line with previous findings
[26]. Depressive symptoms are common in patients with
cardiovascular disease [27-29] and are related to various
behavioral risk factors (eg, sedentary lifestyle, unhealthy diet,
alcohol overconsumption, and smoking) [30,31]; this may
explain the relation between depression and lower lifestyle
behavior scores. Hence, future research is needed to examine
which psychological and clinical factors contributing to health
behavior change and potentially address these factors during
the intervention.
For clinical practice, it is important to acknowledge that
technology and eHealth solutions might be the feasible way
forward in meeting patient needs and initiated health behavior
change. However, the findings of this study underline the
importance of a personalized approach that includes the
assessment of a patient’s demographic, clinical, and
psychological profile.
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In conclusion, the Do CHANGE 1 intervention was perceived
as useful and easy to use. However, no main effects were found
on behavioral flexibility, lifestyle behavior, and quality of life.
More research is warranted to examine which components of
behavioral interventions, and in which patients, are effective in
producing long-term behavior change.
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CAD: coronary artery disease
CAU: care as usual
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PHQ-9: Patient Health Questionnaire 9
SI: social inhibition
UTAUT2: Unified Theory of Acceptance 2
WHOQOL-BREF: World Health Organization Quality of Life—BREF
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